And the data does not capture why each individual was prescribed a GLP-1 medication, which matters because insurance coverage differs significantly depending on whether the medication is prescribed for diabetes, weight management or another indication
Ozempic and longevity The recently published SELECT trial, following 17,604 patients with obesity and cardiovascular disease, compared semaglutide (Ozempic) versus placebo for 3 years
Pairing berberine with cinnamon extract is another trending supplement combination
Semaglutide's data are built on over 25,000 participants across more than 20 randomized controlled trials, including the largest cardiovascular outcomes trial ever conducted for an anti-obesity medication
In order to further extend the half-life of GLP-1, the tightness of the binding of GLP-1 drug molecules to HSA needs to be enhanced